Full-Time
Senior Research Associate
Semiconductors
Oppenheimer & Co. Inc.
Global wealth management and investment bank
Compensation Overview
$100k - $150k/yr
New York, NY, USA
In Person
 Finance & Banking (1) |
|---|
- Must have at least two years of Equity Research experience, Semiconductors preferred.
- Strong financial modeling, accounting, valuation, and quantitative skills. Associates are responsible for building and maintaining integrated income statement, balance sheet, and cash flow models.
- Strong writing and analytical skills. Associates are responsible for writing and producing company initiations, equity research reports, and marketing presentations.
- Strong sales and communication skills. Associates will interact with internal sales and trading and external clients. Responsiveness and professionalism are important.
- Ability to work independently and initiate and accomplish projects with minimal supervision. Self-starters with a strong work ethic are highly desirable.
- Ability to organize, prioritize and manage multiple projects simultaneously.
- PC skills: strong Excel skills and a fair command of Word, PowerPoint, Bloomberg and FactSet.
- Support the Semiconductors team; work in conjunction with and support the senior research analyst in all aspects of developing and marketing equity research products, including company research reports, models, and industry analysis on the Semiconductor supply chain.
- The research associate will work in conjunction with and support the senior research analyst in all aspects of developing and marketing equity research products, including company research reports, models, and industry analysis on the Semiconductor supply chain.
- A passion for the stock market, the technology industry, and equity research.
- Exposure to the financial markets and equity research, and an understanding of the day-to-day responsibilities of an equity research associate; highly advantageous.
Oppenheimer & Co. Inc. is a global financial services firm serving clients since 1881, offering wealth management, capital markets, and investment banking. Services include financial planning, equities and fixed income trading and research, and M&A and capital-raising advisory for institutions and mid-market companies. What sets Oppenheimer apart is pairing over a century of experience with tailored, research-driven strategies for individuals and institutions alike. The goal is to help clients grow and protect wealth across market conditions.
Company Size
N/A
Company Stage
IPO
Headquarters
Minneapolis, Minnesota
Founded
1881
Simplify's Take
What believers are saying
- July 31, 2026 revenue rose 21.9% year over year to $454.9 million.
- Second-quarter 2026 adjusted net income reached $93.2 million, showing operating leverage after litigation.
- Institutional derivatives and infrastructure research hires expand higher-margin businesses into active client demand.
What critics are saying
- May 2026, Oppenheimer settled cash-sweep litigation for $70 million, crushing first-quarter earnings.
- May 2026 FINRA fined Oppenheimer $250,000 for mislabeling 167,000 customer statements.
- Repeated supervision failures invite SEC scrutiny, client flight, and a franchise-damaging trust collapse.
What makes Oppenheimer & Co. Inc. unique
- Oppenheimer combines middle-market investment banking, wealth management, and brokerage under one roof.
- July 2026, Oppenheimer hired seven Guggenheim derivatives veterans, strengthening institutional flow trading.
- July 2026, Brent Thielman joined to deepen infrastructure research across reshoring and digital infrastructure.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Performance Bonus
Company News
Oppenheimer has raised its price target for Snowflake to $400 from $295, citing stronger consumption trends and growing adoption of AI coding agent CoCo. The firm expects product revenue of roughly $1.469 billion, approximately 3% to 4% above consensus, while maintaining its Outperform rating. Analysts said channel checks showed strength across regions and industries, including larger deals and faster migrations. CoCo is helping customers build AI applications whilst encouraging migration of traditional analytics workloads onto Snowflake's platform. In its fiscal first quarter, Snowflake's product revenue grew 34% to $1.33 billion. The company had 779 customers generating over $1 million in trailing-12-month product revenue. Snowflake reports second-quarter results on 2 September.
Advisor moves: Cetera scoops up $420M Commonwealth duo in North Carolina. The Tuckery Bria Wealth Strategies team in North Carolina. Meanwhile, Ameriprise has added a Florida-based veteran formerly with Oppenheimer just as it loses a similarly seasoned professional to Prudential Advisors in New Jersey. AUG 12, 2026 The war for advisor talent continued in earnest this week in the East Coast, with Cetera picking up another Commonwealth team in North Carolina just as Ameriprise welcomes a Florida-based advisor while losing another to Prudential Advisors in New Jersey. Tucker Bria Wealth Strategies moves to Cetera. Durham, North Carolina-based Tucker Bria Wealth Strategies, led by Jim Tucker and Patrick Bria, has joined Cetera through its Summit Financial Networks channel, bringing with it approximately $420 million in assets under administration. The firm's tagline, "Life alters wealth," reflects its focus on financial planning for clients navigating major transitions such as inheritances, business sales and other life events. Tucker and Bria, who have known each other since their teenage years in Pittsburgh and later swam together at Duke University, built the practice together since 2013. The pair spent more than a decade at Commonwealth before LPL Financial's acquisition last year prompted them to evaluate other options, according to Cetera. Their search spanned both traditional broker-dealer and independent registered investment advisor models before they settled on Cetera's Summit community. Continuity was a central consideration, as the firm said it was able to retain its existing custodial relationship with Fidelity's National Financial Services and continue using third-party technology already embedded in its client service workflow. "We wanted a partner strong enough to provide the compliance, technology and back-office support we didn't want to build ourselves, but flexible enough to let us keep running our business exactly the way we always have," Tucker said, highlighting how Summit's "clear reason for being... mattered to us as much as anything else." Tucker Bria's next generation of advisors, including Josh Polidori, Chris Bleeker and Taylor Clement, already serve as primary contacts for many of the practice's second- and third-generation clients, according to the firm. Cetera reported that its advisor network manages approximately $630 billion in assets under administration and $296 billion in assets under management as of March 31. Three-decade veteran departs Oppenheimer for Ameriprise. In Boca Raton, Florida, advisor Mitchell Edenbaum has moved his practice to the branch channel of Ameriprise Financial after departing Oppenheimer & Co., bringing more than $145 million in client assets. Edenbaum, who has spent three decades in the industry, cited the firm's technology platform and what he described as a deep institutional commitment to advisor growth, as well as Ameriprise's strong leadership, as key factors in his decision. "I'm excited about this next chapter and look forward to leveraging the firm's capabilities to continue delivering exceptional service while growing my business," Edenbaum said. He is supported locally by Branch Manager Drew Granauro, Complex Director Dan Landrau and Regional Vice President Mike Rearden, according to Ameriprise. Ameriprise noted that it has added roughly 1,700 advisors over the past five years, a pace the firm has attributed to continued investment in its advisor support infrastructure. Prudential Advisors' NJ Wealth Partners picks up Ameriprise veteran. In Holmdel, New Jersey, longtime advisor Christopher Grella has joined Prudential Advisors' NJ Wealth Partners headquartered in Holmdel, New Jersey. Grella departed Ameriprise, where he most recently served as a vice president overseeing more than $110 million in client assets. Grella's career has spanned Morgan Stanley Dean Witter, Janney Montgomery Scott and MetLife before an extended run as an independent advisor and later at Ameriprise. "I've built my business on my deeply held values of building confidence, transparency, empathy, and personalized guidance to create lasting relationships and seek better outcomes for clients and their families," Grella said. According to his BrokerCheck record, Grella is currently registered as an investment advisor and broker at LPL, which in 2024 completed a partnership deal with Prudential to provide operational support thousands of Prudential's retail advisors. Rob Nigro, managing director at Prudential Advisors, said Grella's emphasis on long-term, generational client relationships aligned with the firm's approach at NJ Wealth Partners, which operates on an open-architecture platform designed for established advisors seeking to scale their practices. Prudential Advisors supports more than 3,000 financial advisors nationally, according to the firm, while parent company Prudential Financial reported approximately $1.6 trillion in assets under management as of June 30.
Oppenheimer & Co. Inc. fined $250,000 by FINRA for mislabeling private-label CMOs. Oppenheimer & Co. Inc., a New York-based brokerage firm with CRD number 249, recently settled a FINRA enforcement action over customer account statements that misidentified private-label collateralized mortgage obligations. The settlement resulted in a $250,000 fine and a firm censure. The case, issued on May 4, 2026, is a clear example of how inaccurate account labels can mislead investors about the nature and risk of their holdings. It also shows that firms must have supervisory systems strong enough to catch categorization errors before they reach thousands of customer statements. The FINRA settlement. Table of Contents FINRA case number 2023077058901 involved a letter of acceptance, waiver, and consent, commonly called an AWC. Oppenheimer agreed to the sanctions without admitting or denying the findings. In addition to the fine and censure, the firm agreed to comply with the undertakings outlined in the AWC. According to the settlement, Oppenheimer generated and sent approximately 167,000 account statements to more than 800 customers. Those statements listed private-label CMOs under the heading "Government Agency Bonds." That heading was inaccurate and misleading because private-label CMOs are not guaranteed by the United States government or a government-sponsored enterprise. After FINRA raised the issue, Oppenheimer changed the label to "Corporate Bonds." That label was also wrong. Private-label CMOs differ from corporate bonds in several respects, including their structure, risk profile, and source of backing. Neither label correctly described the actual investment held by the customer. What FINRA found about Oppenheimer's supervision. FINRA found that Oppenheimer failed to establish and maintain a supervisory system, including written supervisory procedures, reasonably designed to verify the accuracy of customer account statements. The firm's written procedures required a bi-monthly review of a sample of statements, but the review focused mainly on numerical accuracy. The review did not include any step to determine whether customer holdings were accurately categorized. Because of that gap, Oppenheimer did not detect that private-label CMOs were being mislabeled as government agency bonds and then corporate bonds across a large volume of account statements. The case highlights the difference between checking numbers and checking meaning. A statement can show the correct number of shares or principal amount while still giving a customer the wrong impression about what kind of investment is held. A supervisory system that only verifies arithmetic is not enough to protect investors from misleading descriptions. What are private-label CMOs? A private-label collateralized mortgage obligation is a type of mortgage-backed security issued by a private entity rather than a government agency or government-sponsored enterprise. It is backed by pools of residential mortgage loans, but it does not carry the full faith and credit guarantee of the United States government. Government agency bonds and government-sponsored enterprise securities carry explicit or implied backing that private-label CMOs do not. Corporate bonds, by contrast, represent debt issued by companies and are evaluated based on the issuer's creditworthiness. Private-label CMOs do not fit into either category because their performance depends on mortgage cash flows, prepayment risk, and credit risk within the underlying loan pool. When a private-label CMO is labeled as a government agency bond, an investor may believe the position is safer or backed differently than it actually is. That misunderstanding can affect decisions about whether to hold, sell, or purchase more of the security. A label that suggests corporate-bond characteristics can be equally misleading because it ignores the prepayment and default risks tied to the mortgage collateral. The broader regulatory context. Brokerage firms are required to provide accurate account statements under SEC and FINRA rules. Those statements must describe customer holdings in a way that is not false or misleading. Account labels are not just formatting; they communicate the nature of the investment and the source of any backing or guarantee. FINRA has repeatedly emphasized that firms must have supervisory systems reasonably designed to ensure the accuracy of customer communications, including statements. In the Oppenheimer matter, the supervisory review was too narrow to satisfy that obligation. What this means for Oppenheimer customers. Investors who held private-label CMOs at Oppenheimer should review their account statements from the relevant period. Look for holdings described as "Government Agency Bonds" or "Corporate Bonds" that were actually private-label CMOs. If the mislabeling led to a misunderstanding of the investment's risk, and if that misunderstanding caused financial harm, the investor may have a claim. The first step is to gather account statements, trade confirmations, and any notes about why the investment was held or sold. A lawyer can then compare the statement labels to the actual securities and evaluate whether the mislabeling affected investment decisions. Even investors who did not lose money directly may have a claim if the mislabeling caused them to hold a riskier position than intended. The impact depends on the specific facts of each account. How Investment Fraud Lawyers can help. Haselkorn & Thibaut, P.A., operating as Investment Fraud Lawyers, represents investors harmed by inaccurate statements, unsuitable recommendations, and failures in firm supervision. Its attorneys review account records, identify miscategorized holdings, and pursue claims through FINRA arbitration when appropriate. If you held private-label CMOs or other fixed-income investments at Oppenheimer & Co. Inc. and believe you were misled by inaccurate account statements, contact Investment Fraud Lawyers for a free case review. Securities claims have time limits, so acting promptly is important. Call 1-888-885-7162 or reach out online. Investment Fraud Lawyers work on a contingency basis, and past results do not guarantee future outcomes. Frequently asked questions. What is FINRA case 2023077058901? It is the enforcement action in which Oppenheimer & Co. Inc. agreed to a $250,000 fine and censure for mislabeling private-label CMOs on customer account statements. What is a private-label CMO? A private-label collateralized mortgage obligation is a mortgage-backed security issued by a private entity. It is backed by mortgage loans and is not guaranteed by the United States government. Why was the "Government Agency Bonds" label misleading? The label suggested that the CMOs were backed by the government or a government-sponsored entity, which was not true. What did Oppenheimer's supervisory review miss? The bi-monthly review focused on numerical accuracy and did not check whether holdings were correctly categorized. How many account statements were involved? FINRA estimated that Oppenheimer sent approximately 167,000 mislabeled statements to more than 800 customers. Can investors recover losses caused by mislabeled statements? Possibly. If a misleading statement caused an investor to make a decision that resulted in losses, there may be a claim against the firm. How do I start a claim review? Call 1-888-885-7162 or contact Investment Fraud Lawyers online. Investment Fraud Lawyers will review your statements and explain your options at no upfront cost. Disclaimer: Past results do not guarantee future outcomes. This page provides general information and is not legal advice. No attorney-client relationship is formed by reading this content. There is no guaranteed recovery in any securities matter. Consult a qualified attorney regarding your specific situation. Disclaimer: The information contained in any post on this website is derived from publicly available sources and is not guaranteed as to accuracy and often involves allegations which may or may not be proven at some point in the future. All posts are believed to be accurate as of the time of original posting, but the accuracy and details are subject to and expected to change over time and which may contain opinions of the author at the time posted.
Oppenheimer & Co. has expanded its Institutional Derivatives business with the addition of seven senior professionals from Guggenheim Securities. The new hires include Ed Boll as Head of Derivatives Strategy, alongside specialists in sales, trading and technology. The team brings expertise across hedge funds, asset managers and institutional investors, with specialized knowledge in convertible strategies, volatility management and risk arbitrage. Members add sector-specific experience in areas including AI infrastructure, biotech and healthcare derivatives. The expanded group will collaborate with Oppenheimer's existing convertible bonds, high yield, cash equities and prime services divisions. According to John Hellier, Senior Managing Director and Head of Equities, the additions strengthen the firm's Institutional Equities platform by providing comprehensive client support and creating stronger connections across its broader equities franchise. The investment forms part of Oppenheimer's broader effort to develop its institutional platform around areas where expertise and client relationships provide competitive differentiation.
Oppenheimer downgraded IBM to Perform and removed its $350 price target after the company pre-announced weak second-quarter 2026 results ahead of its 22 July earnings call. IBM's results missed estimates across every segment, with total revenue growing just 1% year-over-year to $17.2 billion. Software revenue grew 5% year-over-year, significantly below Oppenheimer's 12% estimate. Infrastructure revenue fell 7% year-over-year, whilst consulting revenue remained flat. Management attributed the shortfall to weakness in Transaction Processing software, shifting buying behaviour towards servers and storage due to memory cost pressures, and large deal slippage at quarter-end. Oppenheimer believes IBM will struggle to achieve double-digit software growth without additional large acquisitions.